Back to BL BAUPOST GROUP LLC/MA

AKBAAKBA
8 quarters

Position history for BLBAUPOST GROUP LLC/MA's holdings in AKEBIA THERAPEUTICS INC

No. The Baupost Group exited its AKBA (Akebia Therapeutics) position in Q3 2020. Its Q2 2020 13F listed 15,000,000 shares worth $203.7M. The Baupost Group already held AKBA in its Q4 2018 13F, the earliest on record, and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$135.3M

Total Shares Change

-24.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q3
Latest
Exited
0
-100.0%
$00.0%$2.39
0
2020-Q2
Decreased
15M
-14.4%
$203.7M2.5%$12.70
0
2020-Q1
Decreased
17.5M
-10.4%
$132.9M2.0%$7.96
0
2019-Q4
Decreased
19.6M
-20.0%
$123.7M1.4%$6.58
0
2019-Q3
Unchanged
24.5M
0.0%
$95.9M1.1%$4.12
0
2019-Q2
Unchanged
24.5M
0.0%
$118.4M1.1%$4.84
0
2019-Q1
Unchanged
24.5M
0.0%
$200.4M1.7%$8.19
0
2018-Q4
First report
24.5M
-
$135.3M1.2%$5.39
0

Other major holders of AKBA: WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used